| BioID | bio44684 |
| Name | NAVOXIMOD |
| ChEMBL ID | CHEMBL3989951 |
| Molecular Formula | C18H21FN2O2 |
| Molecular Weight | 316.38 |
| Molecular Weight (Monoisotopic) | 316.1587 |
| Type | Small molecule |
| Max Phase | Phase 2 |
| Target ID | Tar10 |
| Target Name | P2X purinoceptor 7 (P2RX7) |
| Synonyms | GDC-0919|IDO-IN-7|NAVOXIMOD|NLG-919|NLG919|RG-6078|RG6078|RO-7077339|RO7077339|RO7077339-001 |
| Smiles | O[C@H](C[C@H]1c2c(F)cccc2-c2cncn21)[C@H]1CC[C@H](O)CC1 |
| Inchi | InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11-,12-,15-,17+/m0/s1 |
| Inchi Key | YGACXVRLDHEXKY-WXRXAMBDSA-N |
| Molecular Species | NEUTRAL |
| Targets | 17.0 |
| Bioactivities | 126.0 |
| Np Likeness Score | 0.05 |
| Records Key | ['NAVOXIMOD', 'NLG-919', '15; NLG919', 'GDC-0919', 'NAVOXIMOD', 'NLG-919', '3; GDC-0919', 'Navoximod', 'Navoximod', '1', 'Navoximod', 'GDC-0919', 'NLG-919'] |
| Records Name | ['NAVOXIMOD', '(1R,4r)-4-((R)-2-((S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol', 'Navoximod', '4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[1,5-b]isoindol-5-yl]-1-hydroxy-ethyl]cyclohexanol', 'NAVOXIMOD', 'Navoximod; (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol', 'Navoximod', 'Navoximod', 'Navoximod', 'Navoximod', 'Navoximod', 'Navoximod; (1r,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol', 'Navoximod'] |
| Withdrawn Flag | False |
| Orphan | 0 |